Rubinstein Yaffa R, McInnes Pamela
National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, United States.
Contemp Clin Trials. 2015 May;42:78-80. doi: 10.1016/j.cct.2015.03.003. Epub 2015 Mar 20.
The main goal of the NIH/NCATS GRDR® program is to serve as a central web-based global data repository to integrate de-identified patient clinical data from rare disease registries, and other data sources, in a standardized manner, to be available to researchers for conducting various biomedical studies, including clinical trials and to support analyses within and across diseases. The aim of the program is to advance research for many rare diseases. One of the first tasks toward achieving this goal was the development of a set of Common Data Elements (CDEs), which are controlled terminologies that represent collected data. A list of 75 CDEs was developed by a national committee and was validated and implemented during a period of 2 year proof of concept. Access to GRDR CDEs is freely available at: https://grdr.ncats.nih.gov/index.php?option=com_content&view=article&id=3&Itemid=5. The GRDR CDEs have been the cornerstone of the GRDR repository, as well as of several other national and international patient registries. The establishment of the GRDR program has elevated the issue of data standardization and interoperability for rare disease patient registries, to international attention, resulting in a global dialog and significant change in the mindset of registry developers, patient advocacy groups, and other national and international organizations.
美国国立卫生研究院/国家转化科学推进中心全球罕见病数据资源库(GRDR®)项目的主要目标是作为一个基于网络的中央全球数据存储库,以标准化方式整合来自罕见病登记处及其他数据源的去标识化患者临床数据,供研究人员用于开展各种生物医学研究,包括临床试验,并支持疾病内部和跨疾病的分析。该项目的目的是推动针对多种罕见病的研究。实现这一目标的首要任务之一是开发一套通用数据元素(CDE),即代表所收集数据的受控术语。一个全国委员会制定了一份包含75个CDE的清单,并在为期两年的概念验证期间进行了验证和实施。可通过以下网址免费访问GRDR CDE:https://grdr.ncats.nih.gov/index.php?option=com_content&view=article&id=3&Itemid=5。GRDR CDE一直是GRDR存储库以及其他几个国家和国际患者登记处的基石。GRDR项目的建立已将罕见病患者登记处的数据标准化和互操作性问题提升至国际关注层面,引发了全球范围的讨论,并使登记处开发者、患者权益倡导组织以及其他国家和国际组织的观念发生了重大转变。